Pitavastatin and HDL: Effects on plasma levels and function(s) Angela Pirillo, Alberico L. Catapano Atherosclerosis Supplements Volume 27, Pages e1-e9 (July 2017) DOI: 10.1016/j.atherosclerosissup.2017.05.001 Copyright © 2017 Elsevier B.V. Terms and Conditions
Fig. 1 Chemical structure and metabolic pathways of pitavastatin. Atherosclerosis Supplements 2017 27, e1-e9DOI: (10.1016/j.atherosclerosissup.2017.05.001) Copyright © 2017 Elsevier B.V. Terms and Conditions
Fig. 2 Anti-atherogenic properties of HDL. Atherosclerosis Supplements 2017 27, e1-e9DOI: (10.1016/j.atherosclerosissup.2017.05.001) Copyright © 2017 Elsevier B.V. Terms and Conditions